FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304789069> ?p ?o ?g. }

• W4304789069 abstract "Acute myeloid leukemia (AML) is one of the most common hematopoietic malignancies in adults. The tumor microenvironment (TME) has a critical effect on AML occurrence, recurrence, and progression. The gene feline leukemia virus subgroup C cellular receptor family member 2 (FLVCR2) belongs to the major facilitator superfamily of transporter protein members, which is primarily involved in transporting small molecules. The potential role of FLVCR2 in the TME in AML has not been investigated. To clarify the expression and role of FLVCR2 in AML, we analyzed the Gene Expression Omnibus and The Cancer Genome Atlas databases and found that FLVCR2 mRNA expression significantly increased among patients with AML. Furthermore, based on an analysis of the Gene Expression Profiling Interactive Analysis database, FLVCR2 upregulation predicted dismal overall survival of patients with AML. Our validation analysis revealed the significant upregulation of FLVCR2 within the bone marrow of AML relative to healthy controls by western blotting and qPCR assays. Gene set enrichment analysis was conducted to explore FLVCR2's related mechanism in AML. We found that high FLVCR2 expression was related to infiltration degrees of immune cells and immune scores among AML cases, indicating that FLVCR2 possibly had a crucial effect on AML progression through the immune response. Specifically, FLVCR2 upregulation was negatively related to the immune infiltration degrees of activated natural killer cells, activated memory CD4+ T cells, activated dendritic cells, and CD8+ T cells using CIBERSORT analysis. According to the in vitro research, FLVCR2 silencing suppressed AML cell growth and promoted their apoptosis. This study provides insights into FLVCR2's effect on tumor immunity, indicating that it might serve as an independent prognostic biomarker and was related to immune infiltration within AML." @default.
• W4304789069 created "2022-10-13" @default.
• W4304789069 creator A5003292046 @default.
• W4304789069 creator A5013107472 @default.
• W4304789069 creator A5030050478 @default.
• W4304789069 creator A5031607166 @default.
• W4304789069 creator A5036274351 @default.
• W4304789069 creator A5045703368 @default.
• W4304789069 creator A5051213699 @default.
• W4304789069 creator A5053447705 @default.
• W4304789069 creator A5074990793 @default.
• W4304789069 creator A5087766294 @default.
• W4304789069 date "2022-10-12" @default.
• W4304789069 modified "2023-10-08" @default.
• W4304789069 title "The prognostic marker FLVCR2 associated with tumor progression and immune infiltration for acute myeloid leukemia" @default.
• W4304789069 cites W1976105607 @default.
• W4304789069 cites W1978354625 @default.
• W4304789069 cites W2006636673 @default.
• W4304789069 cites W2021612893 @default.
• W4304789069 cites W2022335352 @default.
• W4304789069 cites W2022905357 @default.
• W4304789069 cites W2023314253 @default.
• W4304789069 cites W2048000549 @default.
• W4304789069 cites W2062745346 @default.
• W4304789069 cites W2102423175 @default.
• W4304789069 cites W2126496132 @default.
• W4304789069 cites W2130381741 @default.
• W4304789069 cites W2130410032 @default.
• W4304789069 cites W2130430382 @default.
• W4304789069 cites W2158217645 @default.
• W4304789069 cites W2232966793 @default.
• W4304789069 cites W2342642001 @default.
• W4304789069 cites W2384094940 @default.
• W4304789069 cites W2530700542 @default.
• W4304789069 cites W2607129810 @default.
• W4304789069 cites W2612021596 @default.
• W4304789069 cites W2626742338 @default.
• W4304789069 cites W2749042075 @default.
• W4304789069 cites W2912293481 @default.
• W4304789069 cites W2916458303 @default.
• W4304789069 cites W2921122028 @default.
• W4304789069 cites W2973116257 @default.
• W4304789069 cites W2978887018 @default.
• W4304789069 cites W2981467355 @default.
• W4304789069 cites W2983326574 @default.
• W4304789069 cites W3006140815 @default.
• W4304789069 cites W3027286012 @default.
• W4304789069 cites W3119509183 @default.
• W4304789069 cites W3172822365 @default.
• W4304789069 cites W3178218847 @default.
• W4304789069 cites W3185073486 @default.
• W4304789069 cites W4200540522 @default.
• W4304789069 cites W4210408888 @default.
• W4304789069 cites W4225568138 @default.
• W4304789069 cites W4231346141 @default.
• W4304789069 doi "https://doi.org/10.3389/fcell.2022.978786" @default.
• W4304789069 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36313565" @default.
• W4304789069 hasPublicationYear "2022" @default.
• W4304789069 type Work @default.
• W4304789069 citedByCount "1" @default.
• W4304789069 countsByYear W43047890692023 @default.
• W4304789069 crossrefType "journal-article" @default.
• W4304789069 hasAuthorship W4304789069A5003292046 @default.
• W4304789069 hasAuthorship W4304789069A5013107472 @default.
• W4304789069 hasAuthorship W4304789069A5030050478 @default.
• W4304789069 hasAuthorship W4304789069A5031607166 @default.
• W4304789069 hasAuthorship W4304789069A5036274351 @default.
• W4304789069 hasAuthorship W4304789069A5045703368 @default.
• W4304789069 hasAuthorship W4304789069A5051213699 @default.
• W4304789069 hasAuthorship W4304789069A5053447705 @default.
• W4304789069 hasAuthorship W4304789069A5074990793 @default.
• W4304789069 hasAuthorship W4304789069A5087766294 @default.
• W4304789069 hasBestOaLocation W43047890691 @default.
• W4304789069 hasConcept C104317684 @default.
• W4304789069 hasConcept C109159458 @default.
• W4304789069 hasConcept C119056186 @default.
• W4304789069 hasConcept C127561419 @default.
• W4304789069 hasConcept C150194340 @default.
• W4304789069 hasConcept C167672396 @default.
• W4304789069 hasConcept C18431079 @default.
• W4304789069 hasConcept C203014093 @default.
• W4304789069 hasConcept C2776107976 @default.
• W4304789069 hasConcept C2778461978 @default.
• W4304789069 hasConcept C2778729363 @default.
• W4304789069 hasConcept C2779282312 @default.
• W4304789069 hasConcept C28328180 @default.
• W4304789069 hasConcept C502942594 @default.
• W4304789069 hasConcept C54355233 @default.
• W4304789069 hasConcept C86803240 @default.
• W4304789069 hasConcept C8891405 @default.
• W4304789069 hasConcept C95444343 @default.
• W4304789069 hasConceptScore W4304789069C104317684 @default.
• W4304789069 hasConceptScore W4304789069C109159458 @default.
• W4304789069 hasConceptScore W4304789069C119056186 @default.
• W4304789069 hasConceptScore W4304789069C127561419 @default.
• W4304789069 hasConceptScore W4304789069C150194340 @default.
• W4304789069 hasConceptScore W4304789069C167672396 @default.
• W4304789069 hasConceptScore W4304789069C18431079 @default.
• W4304789069 hasConceptScore W4304789069C203014093 @default.
• W4304789069 hasConceptScore W4304789069C2776107976 @default.

• next